Considerations on the Dose and Schedule of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Does Dose Matter? Dalgetty M, Cortes J. Blood 2025 Mar 18:blood.2024027944. doi: 10.1182/blood.2024027944.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dalgetty M, Cortes J. Considerations on the Dose and Schedule of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: Does Dose Matter? Blood 2025 Mar 18:blood.2024027944. doi: 10.1182/blood.2024027944.
PMID: 40101136